CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Elite outlines 2028 anticoagulant launch target as NASDAQ uplisting progresses

Positive
AI Analysis

Summary

Elite outlines a 2028 launch target for an anticoagulant product while progressing with NASDAQ uplisting efforts.

Importance:3/10
Sentiment:
0.30
anticoagulantproduct launchNASDAQ uplisting
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 14, 2026 8:27 PM

Read Original